We bring you the latest news from the healthcare about the health care in the United Kingdom.

vrijdag 14 september 2018

Neuropsychopharmacology - Table of Contents alert Volume 43 Issue 11

If you are unable to see the message below, click here to view.
Neuropsychopharmacology
 
TABLE OF CONTENTS

Volume 43, Issue 11

In this issue
Comment
Response
Review Article
Article
Also new
AOP
 

Comment

Reponse to Send et al. telomere length in newborns is related to maternal stress during pregnancy

Kyle C. Esteves, Christopher W. Jones & Stacy S. Drury

Neuropsychopharmacology 2018 43 :2163 - 2163; April 27, 2018; 10.1038/s41386-018-0077-x

 

Abstract | Full Text

Response

Response to the letter by Esteves et al.

T. S. Send, M. Gilles, V. Codd, I. A. C. Wolf, S. Bardtke et al.

Neuropsychopharmacology 2018 43 :2164 - 2164; April 25, 2018; 10.1038/s41386-018-0079-8

 

Abstract | Full Text

Review Article

Regulation of monoamine transporters and receptors by lipid microdomains: implications for depression

Joanne J. Liu, Adrienne Hezghia, Saame Raza Shaikh, Joshua F. Cenido, Ruth E. Stark et al.

Neuropsychopharmacology 2018 43 :2165 - 2179; June 28, 2018; 10.1038/s41386-018-0133-6

 

Abstract | Full Text

Article

Striatal dopamine D2 receptors regulate effort but not value-based decision making and alter the dopaminergic encoding of cost

Ina Filla, Matthew R. Bailey, Elke Schipani, Vanessa Winiger, Chris Mezias et al.

Neuropsychopharmacology 2018 43 :2180 - 2189; July 20, 2018; 10.1038/s41386-018-0159-9

 

Abstract | Full Text

Nicotine effects on associative learning in human non-smokers

Britta Hahn, Ashleigh K. Wells, Agatha Lenartowicz & Marie B. Yuille

Neuropsychopharmacology 2018 43 :2190 - 2196; August 17, 2018; 10.1038/s41386-018-0183-9

 

Abstract | Full Text

Do baseline sub-threshold hypomanic symptoms affect acute-phase antidepressant outcome in outpatients with major depressive disorder? Preliminary findings from the randomized CO-MED trial

Manish K. Jha, Ashley L. Malchow, Bruce D. Grannemann, A. John Rush & Madhukar H. Trivedi

Neuropsychopharmacology 2018 43 :2197 - 2203; August 15, 2018; 10.1038/s41386-018-0180-z

 

Abstract | Full Text

Methylation in OTX2 and related genes, maltreatment, and depression in children

Joan Kaufman, Nicholas F. Wymbs, Janitza L. Montalvo-Ortiz, Catherine Orr, Matthew D. Albaugh et al.

Neuropsychopharmacology 2018 43 :2204 - 2211; July 21, 2018; 10.1038/s41386-018-0157-y

 

Abstract | Full Text

Diffusion imaging markers of bipolar versus general psychopathology risk in youth at-risk

A Versace, CD Ladouceur, S Graur, HE Acuff, LK Bonar et al.

Neuropsychopharmacology 2018 43 :2212 - 2220; May 04, 2018; 10.1038/s41386-018-0083-z

 

Abstract | Full Text

Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder

Elizabeth A. Bartlett, Christine DeLorenzo, Priya Sharma, Jie Yang, Mengru Zhang et al.

Neuropsychopharmacology 2018 43 :2221 - 2230; June 19, 2018; 10.1038/s41386-018-0122-9

 

Abstract | Full Text

Efficacy, tolerability, and cognitive effects of deep transcranial magnetic stimulation for late-life depression: a prospective randomized controlled trial

Tyler S. Kaster, Zafiris J. Daskalakis, Yoshihiro Noda, Yuliya Knyahnytska, Jonathan Downar et al.

Neuropsychopharmacology 2018 43 :2231 - 2238; June 18, 2018; 10.1038/s41386-018-0121-x

 

Abstract | Full Text

Cortico-thalamic hypo- and hyperconnectivity extend consistently to basal ganglia in schizophrenia

Mihai Avram, Felix Brandl, Josef Bäuml & Christian Sorg

Neuropsychopharmacology 2018 43 :2239 - 2248; April 12, 2018; 10.1038/s41386-018-0059-z

 

Abstract | Full Text

Hippocampal glutamate metabolites and glial activation in clinical high risk and first episode psychosis

Shima Shakory, Jeremy J. Watts, Sina Hafizi, Tania Da Silva, Saad Khan et al.

Neuropsychopharmacology 2018 43 :2249 - 2255; July 28, 2018; 10.1038/s41386-018-0163-0

 

Abstract | Full Text

Discrete patterns of cortical thickness in youth with bipolar disorder differentially predict treatment response to quetiapine but not lithium

Wenjing Zhang, Yuan Xiao, Huaiqiang Sun, L. Rodrigo Patino, Maxwell J. Tallman et al.

Neuropsychopharmacology 2018 43 :2256 - 2263; June 18, 2018; 10.1038/s41386-018-0120-y

 

Abstract | Full Text

Genetic association of the cytochrome c oxidase-related genes with Alzheimer's disease in Han Chinese

Rui Bi, Wen Zhang, Deng-Feng Zhang, Min Xu, Yu Fan et al.

Neuropsychopharmacology 2018 43 :2264 - 2276; July 06, 2018; 10.1038/s41386-018-0144-3

 

Abstract | Full Text

Reduced GABAergic cortical inhibition in aging and depression

Jennifer I. Lissemore, Apoorva Bhandari, Benoit H. Mulsant, Eric J. Lenze, Charles F. Reynolds III et al.

Neuropsychopharmacology 2018 43 :2277 - 2284; May 17, 2018; 10.1038/s41386-018-0093-x

 

Abstract | Full Text

Role of gamma-amino-butyric acid in the dorsal anterior cingulate in age-associated changes in cognition

Stefano Marenco, Christian Meyer, Jan Willem van der Veen, Yan Zhang, Ryan Kelly et al.

Neuropsychopharmacology 2018 43 :2285 - 2291; July 03, 2018; 10.1038/s41386-018-0134-5

 

Abstract | Full Text

Overnight memory consolidation facilitates rather than interferes with new learning of similar materials–a study probing NMDA receptors

M. Alizadeh Asfestani, E. Braganza, J. Schwidetzky, J. Santiago, S. Soekadar et al.

Neuropsychopharmacology 2018 43 :2292 - 2298; July 02, 2018; 10.1038/s41386-018-0139-0

 

Abstract | Full Text

Memory enhancing effects of BPN14770, an allosteric inhibitor of phosphodiesterase-4D, in wild-type and humanized mice

Chong Zhang, Ying Xu, Anirudh Chowdhary, David Fox 3rd, Mark E. Gurney et al.

Neuropsychopharmacology 2018 43 :2299 - 2309; August 14, 2018; 10.1038/s41386-018-0178-6

 

Abstract | Full Text

In vivo biased agonism at 5-HT1A receptors: characterisation by simultaneous PET/MR imaging

Benjamin Vidal, Sylvain Fieux, Jérôme Redouté, Marjorie Villien, Frédéric Bonnefoi et al.

Neuropsychopharmacology 2018 43 :2310 - 2319; July 06, 2018; 10.1038/s41386-018-0145-2

 

Abstract | Full Text

Chemokine receptor CCR2 contributes to neuropathic pain and the associated depression via increasing NR2B-mediated currents in both D1 and D2 dopamine receptor-containing medium spiny neurons in the nucleus accumbens shell

Xiao-Bo Wu, Peng-Bo Jing, Zhi-Jun Zhang, De-Li Cao, Ming-Hui Gao et al.

Neuropsychopharmacology 2018 43 :2320 - 2330; June 11, 2018; 10.1038/s41386-018-0115-8

 

Abstract | Full Text

Advertisement
Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours.

Click here to sign up.
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Neuropsychopharmacology.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.

Springer Nature